All Posts
phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ)
Study Name A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies…
🤚🏻 Five for Friday – 5 Awareness Month Testimonials
Home / Blog / [wpbb post:title] Thank you to all who have supported Cholangiocarcinoma Awareness Month so far. Yesterday, February…
🤚🏻 Five for Friday – 5 pages to review in the CCF Annual Report
Home / Blog / [wpbb post:title] CCF is pleased to share the 2022 Fiscal Year Annual Report highlighting the many…
TCS New York City Marathon
Marathon - Sunday, November 3, 2024 New York, New York The fundraising minimum for the 2024 TCS New York City…
🤚🏻 Five for Friday – Social Media
Home / Blog / [wpbb post:title] February is Cholangiocarcinoma Awareness Month. Please be sure to like, comment and share CCF's…
Monthly Scientific Update – February 2023
LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote…
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel Versus Paclitaxel Alone in Adult Patients with Unresectable, Advanced, Metastatic or Recurrent Biliary Tract Cancers Who Have Received One Prior Systemic Chemotherapy Regimen - COMPANION-002
ACTIVE, NOT RECRUITING Study Name A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel Versus Paclitaxel…
🤚🏻 Five for Friday – Awareness Month
Home / Blog / [wpbb post:title] During February, the Foundation invites everyone to participate in Cholangiocarcinoma Awareness Month, a campaign established…
🤚🏻 Five for Friday – Biomarker Stories
Home / Blog / [wpbb post:title] For Cancer Patients, Biomarkers Matter Did you know that cholangiocarcinoma shares mutations with other…
Cholangiocarcinoma Awareness Month
February is Cholangiocarcinoma Awareness Month. The Cholangiocarcinoma Foundation (CCF) invites the community to help educate the public about bile duct…